AI Verdict
LITE has stronger fundamentals based on our AI analysis.
LITE vs LIPO Fundamental Comparison
| Metric | LITE | LIPO |
|---|---|---|
| Revenue | $1.2B | $216,117.0 |
| Net Income | $82.4M | $-3.9M |
| Net Margin | 6.9% | -1,799.1% |
| ROE | 9.7% | -261.4% |
| ROA | 1.7% | -165.5% |
| Current Ratio | 0.61x | 3.24x |
| Debt/Equity | 0.06x | 0.00x |
| EPS | $0.99 | $-1.07 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LITE vs LIPO: Frequently Asked Questions
Is LITE or LIPO a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LITE has stronger fundamentals. LITE is rated SELL (68% confidence) while LIPO is rated STRONG SELL (90% confidence). This is not investment advice.
How does LITE compare to LIPO fundamentally?
Lumentum Holdings Inc. has ROE of 9.7% vs LIPELLA PHARMACEUTICALS INC.'s -261.4%. Net margins are 6.9% vs -1,799.1% respectively.
Which stock pays higher dividends, LITE or LIPO?
LITE has a dividend yield of N/A or no dividend while LIPO has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LITE or LIPO for long term?
For long-term investing, consider that LITE has SELL rating with 68% confidence, while LIPO has STRONG SELL rating with 90% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LITE vs LIPO?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LITE vs LIPO, the AI consensus favors LITE based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.